| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.044 | 0.8 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |